AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Dividend Information and Latest News on Abbott Laboratories Ahead of Its Ex-Dividend Date on Jul 15, 2025
Generated by AI AgentAinvest Dividend Digest
Friday, Jul 11, 2025 9:06 pm ET1min read
Abbott Laboratories has announced a forthcoming dividend, with an ex-dividend date set for Jul 15, 2025. The dividend announcement was made on Jun 13, 2025, and shareholders can expect their dividends on Aug 15, 2025, at a rate of $0.590 per share. This figure is notably higher than the average of the last ten dividends, which stands at $0.287 per share. The company had previously issued a dividend of $0.590 per share on May 15, 2025. Both dividends are categorized as cash dividends.
Recently, experienced a notable shift in its stock value, reflecting broader market trends. As of late, Abbott's stock closed at $132.02, marking a 1.18% decrease from its previous close. Meanwhile, analysts have reiterated a positive outlook for Laboratories, with TD Cowen maintaining a "Buy" rating and a target price of $145. This reflects confidence in Abbott's standing as a $229 billion healthcare leader. Over the past week, Abbott Laboratories has been highlighted for its strong performance against the S&P 500 index, with a notable 18% rise in stock price year-to-date, suggesting robust market positioning.
Since the last update, Abbott Laboratories has garnered attention from analysts and investors alike. has adjusted its target price, now set at $159, reaffirming a "Buy" rating, which underscores the company’s promising financial health and strategic initiatives. Furthermore, recent investments have seen Cerity Partners LLC acquiring 501,200 shares, highlighting institutional confidence in Abbott's potential for growth. This activity aligns with Oppenheimer’s continued "Outperform" rating, reinforcing a bullish sentiment around the company's future prospects.
In conclusion, Abbott Laboratories presents a compelling case for investors, backed by strong financial fundamentals and a positive outlook from industry analysts. The upcoming ex-dividend date on Jul 15, 2025, is crucial for investors looking to benefit from the dividend; purchasing shares after this date will not entitle them to receive the dividend for this cycle.
Recently, experienced a notable shift in its stock value, reflecting broader market trends. As of late, Abbott's stock closed at $132.02, marking a 1.18% decrease from its previous close. Meanwhile, analysts have reiterated a positive outlook for Laboratories, with TD Cowen maintaining a "Buy" rating and a target price of $145. This reflects confidence in Abbott's standing as a $229 billion healthcare leader. Over the past week, Abbott Laboratories has been highlighted for its strong performance against the S&P 500 index, with a notable 18% rise in stock price year-to-date, suggesting robust market positioning.
Since the last update, Abbott Laboratories has garnered attention from analysts and investors alike. has adjusted its target price, now set at $159, reaffirming a "Buy" rating, which underscores the company’s promising financial health and strategic initiatives. Furthermore, recent investments have seen Cerity Partners LLC acquiring 501,200 shares, highlighting institutional confidence in Abbott's potential for growth. This activity aligns with Oppenheimer’s continued "Outperform" rating, reinforcing a bullish sentiment around the company's future prospects.
In conclusion, Abbott Laboratories presents a compelling case for investors, backed by strong financial fundamentals and a positive outlook from industry analysts. The upcoming ex-dividend date on Jul 15, 2025, is crucial for investors looking to benefit from the dividend; purchasing shares after this date will not entitle them to receive the dividend for this cycle.
Ainvest Dividend Digest
Sip from the stream of US stock dividends. Your income play.
Latest Articles
Upbound Group’s $0.39 Cash Dividend: Market Impact and Recovery Outlook for Dec. 17 Ex-Dividend Date
Dec.17 2025
Titan America Announces $0.04 Dividend—Market Impact and Recovery Analysis for 2025-12-17 Ex-Dividend Date
Dec.17 2025
Bny Mellon Municipal Bond Infrastructure Fund Announces $0.042 Dividend; Market Impact on 2025-12-16 Ex-Dividend Date
Dec.16 2025
Global Water Announces Ex-Dividend Date of December 16, 2025 – What Investors Need to Know
Dec.16 2025
Invesco Municipal Income Opportunities Trust Announces Dividend: Market Impact and Recovery Outlook for 2025-12-16 Ex-Dividend Date
Dec.16 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet